AIE is a unique photophysical phenomenon, and its distinctive luminescence properties have demonstrated significant potential in the biomedical field. In urinary system diseases, AIE materials, with ...

MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...

Jyong Biotech develops botanical drugs for urinary disorders. Their lead asset is clearly MCS‑2, which is currently restarting Phase 3 trials after a previous FDA setback. Their pipeline targets large ...

Liv Hospital is a globally trusted healthcare provider, delivering advanced treatments across multiple specialties. With ...